Variant report
Variant | nsv964277 |
---|---|
Chromosome Location | chr4:91110907-91112907 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114234479 | chr4:91110912-91110913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150919430 | chr4:91110962-91110963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183836336 | chr4:91110964-91110965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550565006 | chr4:91111011-91111012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570884954 | chr4:91111035-91111036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115099232 | chr4:91111046-91111047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10516866 | chr4:91111054-91111055 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs78876299 | chr4:91111063-91111064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs71596518 | chr4:91111153-91111154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536139530 | chr4:91111165-91111166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114399097 | chr4:91111180-91111181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576027769 | chr4:91111198-91111199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116104303 | chr4:91111202-91111203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550657052 | chr4:91111205-91111206 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569461592 | chr4:91111315-91111316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs77204561 | chr4:91111371-91111372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545612298 | chr4:91111452-91111453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186695155 | chr4:91111459-91111460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559485683 | chr4:91111466-91111467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11723152 | chr4:91111508-91111509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11940651 | chr4:91111521-91111522 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs191103043 | chr4:91111618-91111619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17016622 | chr4:91111631-91111632 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs530723587 | chr4:91111638-91111639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544191140 | chr4:91111649-91111650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558446553 | chr4:91111692-91111693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184072631 | chr4:91111736-91111737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535758235 | chr4:91111742-91111743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74556712 | chr4:91111759-91111760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140705920 | chr4:91111798-91111799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149754228 | chr4:91111803-91111804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562393467 | chr4:91111805-91111806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569528448 | chr4:91111849-91111850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79342139 | chr4:91111935-91111936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553042688 | chr4:91111967-91111968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146749145 | chr4:91112064-91112065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570388869 | chr4:91112069-91112070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562374696 | chr4:91112091-91112092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555684861 | chr4:91112105-91112106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140352554 | chr4:91112120-91112121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188413297 | chr4:91112121-91112122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572609441 | chr4:91112132-91112133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541972534 | chr4:91112134-91112135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557075196 | chr4:91112192-91112193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541584285 | chr4:91112233-91112234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191620593 | chr4:91112299-91112300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369907005 | chr4:91112332-91112333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572686479 | chr4:91112363-91112364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs575179951 | chr4:91112409-91112410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185394948 | chr4:91112445-91112446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:91109200-91117200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr4:91109200-91118800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:91109400-91119000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr4:91110000-91111200 | Enhancers | Stomach Mucosa | stomach |
5 | chr4:91110000-91111600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr4:91110600-91111000 | Weak transcription | Fetal Brain Female | brain |
7 | chr4:91110800-91111400 | Enhancers | Fetal Brain Male | brain |
8 | chr4:91111000-91111600 | Enhancers | Fetal Brain Female | brain |
9 | chr4:91111400-91112200 | Weak transcription | Fetal Brain Male | brain |
10 | chr4:91111600-91116200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr4:91112200-91112400 | Enhancers | Fetal Brain Male | brain |